AC Immune's Partnership

AC Immune raised a round of funding on July 07, 2016. Investors include Genentech.

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops …

Articles about AC Immune's Partnership: